EP 1105150 A1 20010613 - TREATMENT OF TUMORS WITH OLIGONUCLEOTIDES DIRECTED TO INSULIN-LIKE GROWTH FACTOR-I RECEPTOR
Title (en)
TREATMENT OF TUMORS WITH OLIGONUCLEOTIDES DIRECTED TO INSULIN-LIKE GROWTH FACTOR-I RECEPTOR
Title (de)
BEHANDLUNG VON TUMOREN MIT OLIGONUKLEOTIDEN GEGEN INSULIN ÄHNLICHEN-WACHSTUMFAKTOR-I-REZEPTOR
Title (fr)
TRAITEMENT DE TUMEURS AU MOYEN D'OLIGONUCLEOTIDES AGISSANT SUR LE RECEPTEUR DU FACTEUR DE CROISSANCE INSULUNOIDE I
Publication
Application
Priority
- US 9918306 W 19990813
- US 9635498 P 19980813
- US 11359998 P 19981224
Abstract (en)
[origin: WO0009145A1] A method of inducing resistance to or regression of tumor growth comprising placing tumor cells in culture in vitro or ex vivo supplemented with a pro-apoptotic agent for a period of time, transferring the tumor cells into a diffusion chamber, thereby producing a cell-containing chamber, inserting the chamber into a human for a therapeutically effective time, thereby inducing resistance to or regression of tumor growth.
IPC 1-7
IPC 8 full level
C12N 15/09 (2006.01); A61K 31/711 (2006.01); A61K 35/13 (2015.01); A61K 39/00 (2006.01); A61K 48/00 (2006.01); A61P 35/00 (2006.01); C12N 5/10 (2006.01); C12N 15/113 (2010.01); A61K 35/12 (2015.01); A61K 38/00 (2006.01); C12R 1/91 (2006.01)
CPC (source: EP US)
A61K 35/13 (2013.01 - EP); A61K 39/001103 (2018.08 - EP US); A61P 35/00 (2018.01 - EP); C12N 15/1138 (2013.01 - EP); A61K 38/00 (2013.01 - EP); A61K 2035/126 (2013.01 - EP); A61K 2039/5152 (2013.01 - EP US); A61K 2039/5156 (2013.01 - EP US); C12N 2310/111 (2013.01 - EP); C12N 2310/315 (2013.01 - EP)
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 0009145 A1 20000224; AU 5479899 A 20000306; CA 2339858 A1 20000224; EP 1105150 A1 20010613; JP 2002522506 A 20020723
DOCDB simple family (application)
US 9918306 W 19990813; AU 5479899 A 19990813; CA 2339858 A 19990813; EP 99941078 A 19990813; JP 2000564647 A 19990813